Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems
International Journal of Nanomedicine · 2024
DOI: 10.2147/ijn.s457782 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Jianlan Peng und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Immunotherapy, Immunogenic Cell Death, Neoplasms, Dendritic Cells. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 230 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
- Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou M…
- Guangdong Province Precise Medicine and Big Data Engineering Technology Research Center for Traditional Chinese Medicine, Guangzhou, People's Republic of China.
ORCID-Profile: Shiying Li
Zitieren
APA
Peng, J., Li, S., & Ti, H. (2024). Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s457782
Vancouver
Peng J, Li S, Ti H. Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s457782
BibTeX
@article{Peng2024,
author = {Peng, Jianlan and Li, Shiying and Ti, Huihui},
title = {Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems},
journal = {International Journal of Nanomedicine},
year = {2024},
doi = {10.2147/ijn.s457782}
}
EUVIMED